Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Viemed Healthcare Inc VMD

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment. In-home sleep testing provides in home sleep apnea testing services. Healthcare staffing provides healthcare staffing and recruitment services. The Company provides home medical equipment services through its interest in East Alabama HomeMed, LLC (HomeMed).


NDAQ:VMD - Post by User

Bullboard Posts
Comment by MBAon Dec 18, 2018 9:17am
138 Views
Post# 29128147

RE:RE:RE:Wow.

RE:RE:RE:Wow. As I said before, time and continued record profits are required to change sentiment in this company. With the competitive bid process and subsequent significant drop in price, time (and continued good news (record profit or growth)) are generally required. It takes more than a month and with the markets rolling over, much more time will be required. In the end, the numbers will drive higher valuation however market conditions will drive the multiple. Clearly, the multiples on many stock valuations have dropped over the past 2 to 3 months. VMD is only trading at 6.5 times next years expected EBITDA. Very low for a high growth company but one has to take into account 25% of the revenue base has more risk associated with it. If you do the math, even discounting 100% of this revenue would still put VMD at $6.75 (with a 12x multiple), so the stock is overpriced the potential impact of a competitive bidding process (not a surprise as markets generally over shoot on the high and low side)
Bullboard Posts